Monitoring clinical trials for immune tolerance research
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC)
['FUNDING_OTHER'] · PPD DEVELOPMENT LP · NIH-11095705
This study is all about keeping a close eye on clinical trials that explore how our immune system can learn to ignore certain things, and it's designed for patients who might benefit from new treatments that help manage immune responses safely and effectively.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | PPD DEVELOPMENT LP (nih funded) |
| Locations | 1 site (WILMINGTON, UNITED STATES) |
| Trial ID | NIH-11095705 on ClinicalTrials.gov |
What this research studies
This research focuses on providing thorough monitoring services for clinical trials aimed at understanding immune tolerance, which is how the immune system can be unresponsive to certain antigens. The project ensures that these trials comply with federal regulations and international standards, thereby safeguarding participant welfare and data integrity. Patients involved in these trials may experience cutting-edge treatments that explore how to manage immune responses effectively. The monitoring services also extend to other investigator-initiated studies, enhancing the overall quality of clinical research.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals with conditions that may benefit from enhanced immune tolerance, such as autoimmune disorders or allergies.
Not a fit: Patients with conditions unrelated to immune tolerance or those not participating in the monitored trials may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for conditions related to immune tolerance, potentially benefiting patients with autoimmune diseases or allergies.
How similar studies have performed: Previous research in immune tolerance has shown promising results, indicating that this approach has the potential for significant advancements in treatment.
Where this research is happening
WILMINGTON, UNITED STATES
- PPD DEVELOPMENT LP — WILMINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GLESSNER, MARY — PPD DEVELOPMENT LP
- Study coordinator: GLESSNER, MARY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: National Institute of Allergy and Infectious Disease